Answers are grounded in this paper and cite their sources.
Conformal prediction has been proposed as a distribution-free method for quantifying uncertainty in artificial intelligence (AI) crop-disease classifiers, yet its validity guarantees assume exchangeability between calibration and test data. When multiple diseases co-occur on the same plant, the label space becomes set-valued and the exchangeability assumption is strained in ways that existing evaluations do not address. The framework distinguishes marginal from conditional coverage, defines a co-occurrence-adjusted nonconformity score, and derives bounds on the coverage gap induced by symptom overlap. A replication-based evaluation was conducted using a before-after-control-impact design with a declared variance structure (between-cluster SD = 6.0, residual SD = 4.5, intraclass correlation = 0.64). Power was estimated across 2000 design cells for cluster counts of 8, 16, 24 and 32 and effect sizes of 3, 5 and 8 percentage points. The analysis indicates that 54 clusters are required to detect a 5-percentage-point effect at 80% power. The results show that set-validity degrades systematically as co-occurrence prevalence increases, and that the degradation is not captured by marginal coverage diagnostics. Conditional coverage diagnostics are necessary for responsible deployment of conformal prediction in agricultural disease diagnosis.
No takes yet. Share an insight, caveat, or question.
Abdelkerim et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: